Editor's Corner
Guidance sharpens drug distribution
HOLLIS, NH - Like the case with drug-manufacture outsourcing, handoffs are critical in drug distribution. Especially for drugs that require cold. But in contrast to highly regulated and scrutinized drug manufacturing, the so-called last mile of a drug's journey to the patient is a kind of regulatory Wild West. Report
Analysis
The world's most expensive drugs
Genzyme drugs take four spots among the most expensive in a Forbes survey (chart). The developer's rare disease treatments Myozyme, Fabrazyme, Cerezyme and Aldurazyme all cost over $200,000 per year. But the Cerezyme price is likely to head south following last week's FDA approval of Shire's Gaucher treatment, velaglucerase alfa for injection. Alexion Pharmaceuticals takes the top spot for the world's most expensive drug, Soliris. The therapy costs $409,500 per year. Report
From The Network
Press Releases
- Two Phase 3 Trials Of Sunitinib With Commonly Used Chemotherapies In Advanced Breast Cancer Did Not Meet The Primary Endpoint
- Pfizer Discontinues A Phase 3 Study Of Figitumumab In Previously Treated Patients With Advanced Non-Small Cell Lung Cancer
- Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2009 Financial Results
- GENETIX PHARMACEUTICALS APPOINTS MITCHELL FINER, Ph.D. AS CHIEF SCIENTIFIC OFFICER
- GENETIX PHARMACEUTICALS SECURES $35M IN SERIES B FUNDING
- Clark Johnson Appointed Neurologix President and CEO




